Canine Cancer Alliance
@enddogcancer
Nonprofit foundation supporting research for canine cancer cures and prevention.
ID: 1173569084807467009
16-09-2019 12:07:51
98 Tweet
46 Followers
83 Following
Out on Nature Communications The OXEL study, a phase II trial in patients with triple-negative #BreastCancer post-neoadjuvant therapy ➡️demonstrated: ✅Combination of nivolumab 🧪and capecitabine significantly increased 📈peripheral immunoscore compared to either agent alone